Literature DB >> 29860388

Late-Onset Crohn's Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like Characteristics.

Dalin Li1, Talin Haritunians1, Carol Landers1, Alka A Potdar1, Shaohong Yang1, Hailiang Huang2,3, L Philip Schumm4, Mark Daly2,3, Stephan R Targan1, Dermot P B McGovern1.   

Abstract

Background: Age of onset is linked to variations in clinical phenotypes and natural history in Crohn's disease (CD). We aim to define etiologically more homogenous subgroups in CD based on ages of onset.
Methods: We examined the distribution of CD polygenetic risk score (PRS) across ages of diagnosis in a Caucasian cohort of 2344 independent CD patients. We identified subgroups with a distinct distribution of PRS and compared those groups in genetics, demographic characteristics, clinical subphenotypes, and serological markers. The results were replicated in an independent cohort of 13,065 CD patients from the International Inflammatory Bowel Diseases Genetic Consortium (IIBDGC).
Results: We identified a late-onset (LO) subgroup in CD (age at diagnosis ≥ 55 years) with significantly lower PRS compared with the intermediate group (age at diagnosis between 5 and 55 years) in both cohorts. Smoking cessation, a risk factor for ulcerative colitis (UC) and protective factor for CD, had a higher rate in this LO subgroup in comparison with the intermediate group. We also compared the LO group with the intermediate group, and, consistent with previous reports, the LO group more often had colonic CD, had less penetrating disease behavior, and had less need for surgery. Serological analysis showed that LO CD patients were more antineutrophil cytoplasmic antibody positive and less antisaccharomyces cerevisiae antibody positive compared with the intermediate group. Variance component analysis indicated that overall genetic contribution to LO CD was lower relative to the middle group, and genetic heterogeneity testing indicated that LO CD was different from the middle group in underlying genetic architecture. Conclusions: Late-onset CD is subgroup distinct in genetic and behavioral risk factors with UC-like characteristics. 10.1093/ibd/izy148_video1izy148.video15791413461001.

Entities:  

Mesh:

Year:  2018        PMID: 29860388      PMCID: PMC6195175          DOI: 10.1093/ibd/izy148

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  61 in total

1.  GCTA: a tool for genome-wide complex trait analysis.

Authors:  Jian Yang; S Hong Lee; Michael E Goddard; Peter M Visscher
Journal:  Am J Hum Genet       Date:  2010-12-17       Impact factor: 11.025

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

Review 3.  Recent advances in understanding Crohn's disease.

Authors:  Antonio Di Sabatino; Laura Rovedatti; Francesca Vidali; Thomas Thornton Macdonald; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2011-05-08       Impact factor: 3.397

4.  Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn's disease.

Authors:  A Gustavsson; A Magnuson; B Blomberg; M Andersson; J Halfvarson; C Tysk
Journal:  Aliment Pharmacol Ther       Date:  2012-12-03       Impact factor: 8.171

5.  Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies.

Authors:  Seunggeun Lee; Mary J Emond; Michael J Bamshad; Kathleen C Barnes; Mark J Rieder; Deborah A Nickerson; David C Christiani; Mark M Wurfel; Xihong Lin
Journal:  Am J Hum Genet       Date:  2012-08-02       Impact factor: 11.025

6.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

7.  Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.

Authors:  Stephan R Vavricka; Sabrina M Spigaglia; Gerhard Rogler; Valérie Pittet; Pierre Michetti; Christian Felley; Christian Mottet; Christian P Braegger; Daniela Rogler; Alex Straumann; Peter Bauerfeind; Michael Fried; Alain M Schoepfer
Journal:  Inflamm Bowel Dis       Date:  2011-04-20       Impact factor: 5.325

8.  Increased immune reactivity predicts aggressive complicating Crohn's disease in children.

Authors:  Marla C Dubinsky; Subra Kugathasan; Ling Mei; Yoana Picornell; Justin Nebel; Iwona Wrobel; Antonio Quiros; Gary Silber; Ghassan Wahbeh; Lirona Katzir; Eric Vasiliauskas; Ron Bahar; Anthony Otley; David Mack; Jonathan Evans; Joel Rosh; Maria Oliva Hemker; Neal Leleiko; Wallace Crandall; Christine Langton; Carol Landers; Kent D Taylor; Stephan R Targan; Jerome I Rotter; James Markowitz; Jeffrey Hyams
Journal:  Clin Gastroenterol Hepatol       Date:  2008-07-10       Impact factor: 11.382

9.  A method for identifying genetic heterogeneity within phenotypically defined disease subgroups.

Authors:  James Liley; John A Todd; Chris Wallace
Journal:  Nat Genet       Date:  2016-12-26       Impact factor: 38.330

10.  Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.

Authors:  Isabelle Cleynen; Gabrielle Boucher; Luke Jostins; L Philip Schumm; Sebastian Zeissig; Tariq Ahmad; Vibeke Andersen; Jane M Andrews; Vito Annese; Stephan Brand; Steven R Brant; Judy H Cho; Mark J Daly; Marla Dubinsky; Richard H Duerr; Lynnette R Ferguson; Andre Franke; Richard B Gearry; Philippe Goyette; Hakon Hakonarson; Jonas Halfvarson; Johannes R Hov; Hailang Huang; Nicholas A Kennedy; Limas Kupcinskas; Ian C Lawrance; James C Lee; Jack Satsangi; Stephan Schreiber; Emilie Théâtre; Andrea E van der Meulen-de Jong; Rinse K Weersma; David C Wilson; Miles Parkes; Severine Vermeire; John D Rioux; John Mansfield; Mark S Silverberg; Graham Radford-Smith; Dermot P B McGovern; Jeffrey C Barrett; Charlie W Lees
Journal:  Lancet       Date:  2015-10-18       Impact factor: 202.731

View more
  3 in total

1.  Learning Longitudinal Patterns and Subtypes of Pediatric Crohn Disease Treated With Infliximab via Trajectory Cluster Analysis.

Authors:  Andrew Chen; Ronen Stein; Robert N Baldassano; Jing Huang
Journal:  J Pediatr Gastroenterol Nutr       Date:  2022-03-01       Impact factor: 3.288

Review 2.  Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases?

Authors:  Parambir S Dulai; Siddharth Singh; Niels Vande Casteele; Brigid S Boland; Jesus Rivera-Nieves; Peter B Ernst; Lars Eckmann; Kim E Barrett; John T Chang; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2019-04-19       Impact factor: 13.576

Review 3.  Challenges of Clustering Multimodal Clinical Data: Review of Applications in Asthma Subtyping.

Authors:  Elsie Horne; Holly Tibble; Aziz Sheikh; Athanasios Tsanas
Journal:  JMIR Med Inform       Date:  2020-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.